.png)
Technologies & Applications
-
Magnetofection Technology
Magnetofection™ is a simple and highly efficient transfection method to transfect primary cells and hard to transfect cells. Inspired by the... -
Lipofection Technology
PRINCIPLE Lipofection is a lipid-based transfection technology which belongs to biochemical methods including also polymers, DEAE dextran and... -
Custom mRNA Synthesis Service
OZ Biosciences offers mRNAs that mimic fully processed mature mRNAs. These mRNAs are stabilized with 5’ Cap 1 structure and 3’ poly(A) tail and are... -
I-MICST Technology
PRINCIPLE i-MICST™ Technology (integrated Magnetic Immuno-Cell Sorting and Transfection/ Transduction) is a new platform that allows to genetically... -
CRISPR/Cas9 Genome Editing Transfection Reagents
“Genome editing” or “Genome engineering” gives the ability to introduce a variety of genetic alterations (deletion, insertion…) into mammalians... -
Magnetic plates & starting kits
The Magnetofection™ technology requires appropriate magnetic fields that magnetize nanoparticles in solution, forms a very strong gradient to... -
In vivo Magnetofection™
The main problems currently associated with systemic gene vector administration (gene therapy) include biodistribution of gene vector throughout... -
3D Transfection
PRINCIPLE Three-dimensional (3D) matrices, such as 3D-scaffolds and 3D-hydrogels, work as mechanical platforms for cell attachment and growth.... -
Virus concentration
PRINCIPLE Mag4C magnetic nanoparticles capture viruses in culture medium by electrostatic and hydrophobic interactions with 80-99 % efficiency.... -
Stem workflow
HOW DOES IT WORK? Stem cells are widely investigated due to their regenerative potential. In many cases, it would prove useful to enhance or... -
Neurosciences
Explore different solutions to improve your transfection for Neuroscience Applications. Microglial, neurons and brain transfection. -
Vaccine adjuvants
For Vaccination Research Immune responses are categorized into two types: innate and adaptive (Figure 1). Cells of the innate immune system... -
Bioproduction
Optimized transfection kits for large-scale bioproduction in CHO and HEK293 suspension cells. Produce recombinant proteins, antibodies and... -
NanOZ-LNP Lipid NanoParticles
Highly Potent Non-Viral Drug Delivery Nanosystems The Need of Advanced Delivery Systems Nevertheless, naked mRNA therapeutics are generally... -
Polyfection Technology
A New Transfection Reagent, not Just Another One After the development of Lipofection (lipid-based transfection method) and Magnetofection... -
Custom saRNA Synthesis Service
Self-amplifying RNAs (saRNAs) also called “Replicons” are the next generation of RNA vaccines. Their advantage over conventional mRNA vaccine...
22
Years of expertise in biotechnology
2500+
Publications using our products
140+
Life sciences reagents developed
Popular Products
-
LentiBlast Premium...
Lentivirus / Retrovirus -
NeuroMag
Neurons -
ViroMag R/L
Lentivirus / Retrovirus -
Lullaby Transfection Reagent
Cell Lines -
DreamFect
DNA transfection reagents -
FluoMag
Fluorescent Magnetofection...
-
DreamFect Stem
Stem Cells -
DreamFect Gold
DNA transfection reagents
-
ETV2 functions as a pioneer factor to regulate and reprogram the endothelial lineage” by Gong, Wuming, et al. in Nature Cell Biology (2022) Cultured iHA-Etv2 MEFs were infected with lentiviruses using the LentiBlast Premium Trasduction Enhancer.
Reagent finder
Citation database
We're proud to be trusted by over 35 distributors worldwide
News
-
Glioma-induced DNMT3A reduction in microglia promotes an anti-tumoral phenotype
Authors: Cheray, M., Posada-Pérez, M., Fragkopoulou, A. et al. Source: Cell Death Differ (2026). They discovered that a transient reduction in DNA methylation... -
CRISPR-based functional genomics in primary acute myeloid leukemia samples
Authors: Cao Z, Yu S, Peng J et al. Source: Molecular Cell. They developed an optimized CRISPR-based platform for functional genomics in patient-derived xenograft (PDX)... -
Enhancing transduction efficiency of lentiviral vectors in CAR-T cell therapy
Authors: Ferreira R et al. Source: Front. Med. The stepwise optimization developed in this study brought transduction efficiency of the anti-FITC-CAR construct from an average of ~1% to ~50%